Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin
✍ Scribed by E. C. De Boer; W. H. De Jong; A. P. M. Van Der Meijden; P. A. Steerenberg; J. A. Witjes; P. D. J. Vegt; F. M. J. Debruyne; E. J. Ruitenberg
- Publisher
- Springer-Verlag
- Year
- 1991
- Tongue
- English
- Weight
- 885 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Molecular markers reliably predicting failure or success of Bacillus Calmette‐Guérin (BCG) in the treatment of nonmuscle‐invasive urothelial bladder cancer (NMIBC) are lacking. The aim of our study was to evaluate the value of cytology and chromosomal aberrations detected by fluorescenc
The effects of bacillus Calmette-Guerin (BCG) on the cytotoxic activities of peripheral blood lymphocytes against human T24 lined and freshly separated autologous urinary bladder transitional carcinoma cells in patients with urinary bladder cancer were analyzed in a 12-hour chromium 51 ( 51Cr) relea